Immunodiagnostic Systems Holdings plc provided earnings guidance for the full year ended March 31, 2013. For the year, the company's total revenues are expected to be £49.8 million compared to £53.7 million in 2012. The revenue performance is encouraging particularly given the tough trading environment due to a rapidly declining manual 25OH Vitamin D market, significantly increased automated vitamin D competition and ongoing laboratory consolidation, predominantly in the French market. The group's operations have generated £13.6 million of cash during the year (2012: £6.7 million before loan repayments). The board maintains the view that overall revenues in 2013 and 2014 will be in line with the previous financial year.

Chris Yates joined the company on March 4, 2013 as the company's new Finance Director. In addition, the senior management team was strengthened further by the appointment of Dr. Karim Tabiti as Head of Strategic Marketing, and Nicola Trewin as Group HR Manager.